A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2025

Primary Completion Date

May 24, 2027

Study Completion Date

May 24, 2027

Conditions
Glucocorticoid-induced Osteoporosis
Interventions
DRUG

Prolia®

Subcutaneous (SC) injection in pre-filled syringe.

Trial Locations (10)

100050

RECRUITING

Beijing Friendship Hospital Capital Medical University, Beijing

130021

RECRUITING

The First Bethune Hospital of Jilin University, Changchun

200052

RECRUITING

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai

213003

RECRUITING

The First Peoples Hospital of Changzhou, Changzhou

310014

RECRUITING

Zhejiang Provincial Peoples Hospital, Hangzhou

510180

RECRUITING

Guangzhou First Peoples Hospital, Guangzhou

518020

RECRUITING

Shenzhen Peoples Hospital, Shenzhen

610072

RECRUITING

Sichuan Provincial Peoples Hospital, Chengdu

710061

RECRUITING

The First Affiliated Hospital of Xi An Jiaotong University, Xi'an

030000

RECRUITING

First Hospital of Shanxi Medical University, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY